Histone H3 lysine 4 demethylation is a target of nonselective antidepressive medications.
about
The emerging role of histone lysine demethylases in prostate cancerCross-talk between histone modifications in response to histone deacetylase inhibitors: MLL4 links histone H3 acetylation and histone H3K4 methylationHistone modifications, DNA methylation, and schizophreniaDiet and the epigenetic (re)programming of phenotypic differences in behaviorEpigenetics in mood disordersEpigenetic mechanisms in drug addictionEpigenetic principles and mechanisms underlying nervous system functions in health and diseaseHistone demethylase LSD1 controls the phenotypic plasticity of cancer cellsInduced Pluripotent Stem Cells: Generation Strategy and Epigenetic Mystery behind ReprogrammingTherapeutic opportunities in Ewing sarcoma: EWS-FLI inhibition via LSD1 targetingFetal globin gene repressors as drug targets for molecular therapies to treat the β-globinopathiesEpigenomics of leukemia: from mechanisms to therapeutic applicationsCurrent status and future prospects for epigenetic psychopharmacologyActive DNA demethylation in post-mitotic neurons: a reason for optimismThe role of histone demethylases in cancer therapyEpigenetics in breast cancer: what's new?Extracellular-vesicle type of volume transmission and tunnelling-nanotube type of wiring transmission add a new dimension to brain neuro-glial networksTrials with 'epigenetic' drugs: an updateEpigenetics of the depressed brain: role of histone acetylation and methylationEpigenetic mechanisms in mood disorders: targeting neuroplasticityA High-Throughput Mass Spectrometry Assay Coupled with Redox Activity Testing Reduces Artifacts and False Positives in Lysine Demethylase ScreeningInhibitors of MAO-A and MAO-B in Psychiatry and NeurologyEpigenome-based personalized medicine in human cancerKDM1 class flavin-dependent protein lysine demethylasesEpigenetic regulation of endothelial-cell-mediated vascular repairLysine-specific demethylase 1 (LSD1) is highly expressed in ER-negative breast cancers and a biomarker predicting aggressive biologyLSD1 inhibition: a therapeutic strategy in cancer?Lysine-specific demethylase 1 as a potential therapeutic targetExpanding the druggable space of the LSD1/CoREST epigenetic target: new potential binding regions for drug-like molecules, peptides, protein partners, and chromatinHistone deacetylase inhibition alters histone methylation associated with heat shock protein 70 promoter modifications in astrocytes and neuronsHistone demethylase LSD1 regulates neural stem cell proliferationLSD1 Histone Demethylase Assays and InhibitionErasing the methyl mark: histone demethylases at the center of cellular differentiation and diseaseImpairment of prostate cancer cell growth by a selective and reversible lysine-specific demethylase 1 inhibitor.Maternal separation with early weaning: a rodent model providing novel insights into neglect associated developmental deficitsConversion of mouse epiblast stem cells to an earlier pluripotency state by small molecules.Silencing of odorant receptor genes by G protein βγ signaling ensures the expression of one odorant receptor per olfactory sensory neuron.Neuronal Stress Pathway Mediating a Histone Methyl/Phospho Switch Is Required for Herpes Simplex Virus Reactivation.Lysine-specific demethylase 1 (LSD1) Is required for the transcriptional repression of the telomerase reverse transcriptase (hTERT) gene.ZNF198 stabilizes the LSD1-CoREST-HDAC1 complex on chromatin through its MYM-type zinc fingers
P2860
Q21245762-A3799C3B-3308-4E03-8BFD-C4FB4C751B8CQ24336402-3C1AA24F-D438-4A99-AF32-EAD40798AD0FQ24606593-223C2897-896B-47BA-8CEE-5B38EFB7963DQ24634401-D365E8CF-8167-4A4E-8496-005139649943Q24644659-B9DFEDA5-81D8-4AE5-B957-FA6938CE5B15Q24645709-B7D0933E-BD5E-4912-B6D5-50D869DF6E72Q24657549-900D3B65-DA1C-4874-8261-D2CAE0763E61Q26745452-37DDD9C5-4CCE-4DCA-B744-F6CC4D4826C0Q26765848-6EC2B80B-DFA1-438B-822A-B481A7EBACB4Q26768602-0D8D1682-B182-418D-BD9D-F6B30EE1BAFAQ26822810-C8416254-4798-4C17-AE0D-E97F1F9B8A68Q26823403-CF37C38C-2FE2-4239-A35C-DD8FBC8AE2B8Q26825464-FB4F9BF2-B8AA-4DC6-AB38-666286348A9BQ26829515-A09BA771-FA96-4BC6-A868-0787845884D1Q26864687-782649A1-6158-4ADB-A9BA-DD0D6D65B511Q26991779-557119E3-611E-4458-BD37-E8795B8910EAQ26995083-62CCE8E2-F08E-480E-8601-1A394844ADDCQ27000542-04AD3F0E-4A21-43C1-96AB-C550A9E7B5BFQ27015084-2652CF9F-3F5C-4A1F-ABE2-839D6F76D1E5Q27021810-8072C6BE-FF2E-449E-AF82-04445416C18CQ27698149-8EB85F1E-813C-4E07-A4D5-AA5C34C5C5DEQ28069609-1C5207A1-CDF0-4DBB-A4DC-9524AD264D86Q28083951-DE83481A-ACA3-4B3A-AB40-5C6CA3111496Q28084876-10E1EEA5-2BF4-46D9-A729-BE4ADF091484Q28085420-76C3C8ED-E5BD-428D-8CB1-9AAA2C54CDE5Q28269080-00E84D11-AF04-44B2-8E37-79BB3FA5A441Q28274561-E5E99357-000F-4F7A-8F2C-406F2634E85CQ28302363-8DBBB181-FA82-48D0-9793-F0F311092D5CQ28534702-426151E8-C2EF-43F5-B754-AE30351613AFQ28571794-5A9F71E1-322B-402A-86B7-DB0333665DE4Q28589881-41E225BA-BF65-4A4B-98C9-AE2809F69508Q28818766-BC00483F-03E5-41BB-ABC3-A095D40D5670Q29617086-A91833E9-8209-4FCE-8A82-4AD812331CF6Q30414643-D145DE70-EA94-4182-B94D-83A0591777A3Q30453556-4FDA50E1-5554-4886-91CD-3C1FD7DA7AA7Q30496670-032FE56C-A7E8-4FEC-8AC5-E24F7B97D3BEQ30644767-F1F793A6-4D14-412F-8E1D-3C02C5F83FDCQ30689513-6127D172-6739-4379-B899-01986ABFB8E3Q33314914-72B2023E-DCFB-4B04-9876-87466BCFF934Q33370931-371CAE71-CC8E-498B-B2C1-555E2834184A
P2860
Histone H3 lysine 4 demethylation is a target of nonselective antidepressive medications.
description
2006 nî lūn-bûn
@nan
2006 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2006 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
name
Histone H3 lysine 4 demethylation is a target of nonselective antidepressive medications.
@ast
Histone H3 lysine 4 demethylation is a target of nonselective antidepressive medications.
@en
type
label
Histone H3 lysine 4 demethylation is a target of nonselective antidepressive medications.
@ast
Histone H3 lysine 4 demethylation is a target of nonselective antidepressive medications.
@en
prefLabel
Histone H3 lysine 4 demethylation is a target of nonselective antidepressive medications.
@ast
Histone H3 lysine 4 demethylation is a target of nonselective antidepressive medications.
@en
P2093
P1476
Histone H3 lysine 4 demethylation is a target of nonselective antidepressive medications.
@en
P2093
Christopher Wynder
Dawn M Schmidt
Dewey G McCafferty
Min Gyu Lee
Ramin Shiekhattar
P304
P356
10.1016/J.CHEMBIOL.2006.05.004
P577
2006-06-01T00:00:00Z